Business
The ASX healthcare shares Goldman Sachs rates as a buy
Goldman Sachs hosted its 4th small/mid-cap healthcare forum this week. This included 13 Australian and New Zealand healthcare companies across a diverse range of specialties. Here are the ASX healthcare shares that Goldman picked as a buy.
Goldman’s ASX healthcare shares to buy
Opthea Ltd (ASX: OPT)
Opthea is developing a complementary medicine to be used with existing inhibitors for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).
Goldman believes there is multi-billion dollar potential in Opthea’s treatment. The broker observes that existing treatments only inhibit up to two of the factors responsible for retinal disease, with over half of patients not achieving…
-
Noosa News20 hours agoLNP Premier David Crisafulli announces ‘Queensland’s royal commission’ into CFMEU
-
Noosa News21 hours agoSouthern NSW farmers call for financial relief as ongoing drought takes a toll
-
Noosa News20 hours agoMan stabbed in physical altercation on the Sunshine Coast
-
General16 hours agoAlgal bloom ‘disaster’ prompts royal commission call as impact spreads to mussel farms